DuPont formed, in February 2000, an independent panel to guide our actions, help us consider and address important issues, and guide and challenge us in the development, testing and commercialization of new products based on biotechnology. The advisory panel audits the Company's progress and provides a public report on a regular basis. Panel members rotate off after a period of time in order to bring in new perspectives. View a list of Panel Alumni who have contributed important perspectives to DuPont.
The current members of the DuPont external Biotechnology Advisory Panel are listed below.
Marcelo Carvalho de Andrade, M.D.
Founding Chairman of Pro-Natura
Panel member from November 2004 to present
Jason Clay, Ph.D.
Vice President and Managing Director, Markets, World Wildlife Fund – U.S.
Panel member from April 2007 to present
Father Kevin T. FitzGerald, S.J., Ph.D.
Research Associate Professor in the Department of Oncology at Georgetown University Medical Center, and the Dr. David Lauler Chair in Catholic Health Care Ethics
Panel member from November 2003 to present
Vice President, Eastern Africa Farmers Federation
Panel Member from October 2005 to present
Deepak Pental, Ph.D.
Professor of Genetics and Vice Chancellor for the University of Delhi
Panel member from May 2008
Sven Thormahlen, Ph.D.
Vice President, Research and Development Organization of the Danone Group
Panel member from March 2004 to present